Holen Sie sich die Stockscreener-App
1.67
4.07%
-0.05
Schlusskurs vom Vortag:
$1.72
Offen:
$1.75
24-Stunden-Volumen:
104.38K
Relative Volume:
1.18
Marktkapitalisierung:
$12.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-17.43M
KGV:
-0.4485
EPS:
-3.7237
Netto-Cashflow:
$-14.32M
1W Leistung:
+4.43%
1M Leistung:
+16.20%
6M Leistung:
+6.45%
1J Leistung:
+44.74%
1-Tages-Spanne:
$1.63
$1.7699
1-Wochen-Bereich:
$1.56
$1.78
52-Wochen-Spanne:
$0.88
$9.56
Biovie Inc Stock (BIVI) Company Profile
Firmenname
Biovie Inc
Sektor
Branche
Telefon
775-888-3162
Adresse
680 W NYE LANE, CARSON CITY
Compare BIVI vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.65 | 12.44M | 0 | -17.43M | -14.32M | -3.7237 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-01-15 | Eingeleitet | B. Riley Securities | Buy |
Biovie Inc Aktie (BIVI) Neueste Nachrichten
BioVie advances long COVID trial, top-line data expected by summer - Proactive financial news
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
BioVie Investor Deadline Approaching - TMX Newsfile
What influences BioVie (BIVIW) stock price action |Crowd Sentiment Stocks - Newser
BIVIW Price History for Biovie WT Stock - Barchart.com
BioVie to host KOL event highlighting Bezisterim's potential in Parkinson's Disease - Proactive financial news
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026 - ChartMill
A Parkinson's disease expert joins BioVie webcast ahead of Phase 2 data - Stock Titan
Why United Rentals Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Sahm
BioVie stock dips on pricing $12M securities offering - MSN
BioVie (BIVI) Market Position | Q3 2025: Better Than ExpectedCommunity Driven Stock Picks - Cổng thông tin điện tử tỉnh Tây Ninh
Is BioVie (BIVI) stock showing bullish signals today | BioVie Inc. Delivers 13.5 Percent EPS Beat Topping Analyst EstimatesTrending Entry Points - Cổng thông tin điện tử tỉnh Tây Ninh
BIVIW (BioVie) PS Ratio : (As of Apr. 27, 2026) - GuruFocus
BIVIW (BioVie) Cyclically Adjusted PB Ratio : (As of Apr. 22, 2026) - GuruFocus
BIVIW (BioVie) Cyclically Adjusted PS Ratio : (As of Apr. 27, 2026) - GuruFocus
BIVIW (BioVie) EV-to-EBIT : 0.00 (As of Apr. 22, 2026) - GuruFocus
BioVie Inc (BIVIW) Valuation - GuruFocus
BioVie Inc (BIVIW) Competitors 2026 - GuruFocus
BioVie Inc (BIVIW) Stock HoldersInstitutional & Insider Ownership - GuruFocus
BIVIW (BioVie) Net Income From Continuing Operations : $-17.43 Mil (TTM As of Dec. 2025) - GuruFocus
BioVie Inc (NAS:BIVIW) Stock News, Headlines & Updates - GuruFocus
Who's Buying or Selling BioVie Inc (BIVIW) Stock Today? - GuruFocus
BioVie Inc (BIVIW) Stock Earnings Transcripts - GuruFocus
BioVie Inc (BIVIW) Dividend - GuruFocus
BioVie Inc (BIVIW) Insider Trading Activity | Apple Insider Buys and Sells - GuruFocus
BioVie Inc (BIVIW)Valuation Measures & Financial Statistics - GuruFocus
BioVie (BIVI) Stock: Investment Case Evaluation (-0.96%) 2026-04-20Target Price - Cổng thông tin điện tử Tỉnh Sơn La
BioVie (BIVI) Stock: Undervalued? (Overhead Buying) 2026-04-18Community Risk Signals - Cổng thông tin điện tử tỉnh Lào Cai
BIVI: Imminent clinical data for Parkinson's and long COVID could unlock major market opportunities - TradingView
BIVI: Imminent clinical readouts for Parkinson's and long COVID could unlock multi-billion dollar markets - TradingView
BIVI Financial Blogger Activity - Investing.com Australia
Small cap wrap: 374Water, Replenish Nutrients, Purepoint Uranium, BioVie… - Proactive Investors
Early Parkinson's trial data from BioVie heads to Chicago meeting - Stock Titan
BioVie abstract on Parkinson’s drug accepted for neurology conference - Proactive financial news
BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting - Bitget
Is trend weakening for BioVie (BIVIW) Stock | Price at $0.25, Down 4.94%Community Buy Signals - Cổng thông tin điện tử tỉnh Lào Cai
BioVie CEO explains Bezisterim Parkinson’s trial resultsICYMI - Proactive Investors
Fundamentals Check: Will BioVie Inc outperform the market in YEAR2026 Review & Precise Entry and Exit Recommendations - baoquankhu1.vn
BioVie targets neuroinflammation and insulin resistance in Parkinson’s treatment approach - Proactive financial news
BIVI Technical Analysis & Stock Price Forecast - Intellectia AI
Rally Mode: What drives BioVie Incs stock priceTrade Ideas & Weekly Top Gainers Alerts - baoquankhu1.vn
Will BioVie (BIVI) Stock Hit New Highs | Price at $1.44, Up 1.69%Crowd Entry Signals - Xã Thanh Hà
If You Invested $1,000 in Biovie Inc (BIVI) - Stock Titan
Trend Report: Will BioVie Inc stock go up in YEAR2026 Movers & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Is BioVie (BIVI) Stock Good for Beginners | Price at $1.35, Down 6.25%Hot Momentum Watchlist - Cổng thông tin điện tử Tỉnh Sơn La
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Shareholders to Reach Out - ACCESS Newswire
BIVIW Stock Analysis: BioVie Inc. Biotech Warrant Flat at 0.33, Full Performance Review - Cổng thông tin điện tử tỉnh Lào Cai
BIVI Should I Buy - Intellectia AI
Aug Gainers: Is BioVie Inc a turnaround story2026 Major Catalysts & Reliable Price Breakout Alerts - baoquankhu1.vn
BioVie targets Parkinson’s at its source with lead drug bezisterim - Proactive financial news
Analyst Downgrade: Will BioVie Inc outperform the market in YEARQuarterly Investment Review & AI Based Trade Execution Alerts - baoquankhu1.vn
Finanzdaten der Biovie Inc-Aktie (BIVI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):